BioDot to Co-market Quantiscientifics Microarray System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Privately held Quantiscientifics today said that BioDot will co-market and sell its A2 MicroArray System.

The A2 system allows for multiplexing in a 96-well plate format. The system was initially developed at Beckman Coulter and enables multiplexing of antibodies, peptides, antigens, and biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.